.
BioEnterprise

June 2017

May 2017

Opening the Door to Hospital Sales: “Strategic Keys to Success: Planning and Commercialization Strategies”

It is critically important to have a robust commercialization strategy in order to develop and sell a new medical device or diagnostic product to hospitals. In this session, experienced industry professionals and specialized consultants will discuss the critical elements that need to be addressed, including the importance of claims to support regulatory requirements and marketing and sales objectives. Keep Reading »

MedCity INVEST 2017 – Aram Nerpouni, President and CEO, BioEnterprise, “Trends in Midwest Investing”

Focusing on digital health, biopharma, and medical devices, a discussion of Midwest deals and funding raised. What is trending and which states are at the forefront of accelerating innovation? How the Midwest compares to the U.S. as a whole. Keep Reading »

April 2017

March 2017

February 2017

Record Number of Midwest Healthcare Startups Raise $1.7 Billion in 2016

Aram Nerpouni As a sign of the Midwest’s continued growth as an engine of biomedical commercialization, a record 375 Midwest healthcare companies raised $1.7 billion in 2016, the second largest amount recorded. Keep Reading »

2016- Midwest Healthcare Companies Raise $1.7 Billion

Midwest healthcare companies attracted $1.7 billion in new equity investments in 2016, according to the BioEnterprise Midwest Healthcare Growth Capital Report. Keep Reading »

January 2017